Stay updated on Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial

Sign up to get notified when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T22:26:53.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the safety, tolerability, and efficacy of epacadostat in combination with immune therapies for participants with advanced or metastatic malignancies.
    Difference
    0.2%
    Check dated 2024-06-06T14:35:28.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed information about eligibility criteria for participants, including specific inclusion and exclusion criteria for different phases of the study. Previously, this section had no information provided.
    Difference
    18%
    Check dated 2024-05-22T21:19:23.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:32:14.000Z thumbnail image

Stay in the know with updates to Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.